Transurethral Prostatic Delivery Device and Implant
- UID
- IMP/MD/2023/000915_859fc0f72441a65256c3a5529c23e86b_429fbae187b035c19dc457014c9232fe
- Device class
- Class C
- Brand name
- UROLIFT
- License holder
- Teleflex Medical Private Limited
- Approving authority
- CDSCO
- Product information
- The UroLift System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (UROLIFT) in men 50 years of age or older.
Transurethral Prostatic Delivery Device and Implant is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2023/000915_859fc0f72441a65256c3a5529c23e86b_429fbae187b035c19dc457014c9232fe. This device is marketed under the brand name UROLIFT. The license holder is Teleflex Medical Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.